keyword
https://read.qxmd.com/read/38625896/exposure-to-low-levels-of-heavy-metals-and-chronic-kidney-disease-in-the-us-population-a-cross-sectional-study
#21
JOURNAL ARTICLE
Akintayo Akinleye, Olayinka Oremade, Xiaohui Xu
BACKGROUND: Exposure to heavy metals (cadmium, mercury, and lead) has been linked with adverse health outcomes, especially their nephrotoxic effects at high levels of exposure. We conducted a replication study to examine the association of low-level heavy metal exposure and chronic kidney disease (CKD) using a larger NHANES data set compared to previous studies. METHODS: The large cross-sectional study comprised 5,175 CKD cases out of 55677 participants aged 20-85 years from the 1999-2020 National Health and Nutrition Examination Survey [NHANES]...
2024: PloS One
https://read.qxmd.com/read/38625739/the-secreted-micropeptide-c4orf48-enhances-renal-fibrosis-via-an-rna-binding-mechanism
#22
JOURNAL ARTICLE
Jiayi Yang, Hongjie Zhuang, Jinhua Li, Ana B Nunez-Nescolarde, Ning Luo, Huiting Chen, Andy Li, Xinli Qu, Qing Wang, Jinjin Fan, Xiaoyan Bai, Zhiming Ye, Bing Gu, Yue Meng, Xingyuan Zhang, Di Wu, Youyang Sia, Xiaoyun Jiang, Wei Chen, Alexander N Combes, David J Nikolic-Paterson, Xueqing Yu
Renal interstitial fibrosis is an important mechanism in the progression of chronic kidney disease (CKD) to end-stage kidney disease. However, we lack specific treatments to slow or halt renal fibrosis. Ribosome profiling identified upregulation of a secreted micropeptide, C4orf48 (Cf48), in mouse diabetic nephropathy. Cf48 RNA and protein levels were upregulated in tubular epithelial cells in human and experimental CKD. Serum Cf48 levels were increased in human CKD and correlated with loss of kidney function, increasing CKD stage, and the degree of active interstitial fibrosis...
April 16, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38625700/anti-tumor-necrosis-factor-therapy-and-risk-of-kidney-function-decline-and-mortality-in-inflammatory-bowel-disease
#23
JOURNAL ARTICLE
Keiichi Sumida, Prabin Shrestha, Yamini Mallisetty, Fridtjof Thomas, Geeta Gyamlani, Elani Streja, Kamyar Kalantar-Zadeh, Csaba P Kovesdy
IMPORTANCE: Inflammatory bowel disease (IBD) is associated with adverse clinical outcomes, including chronic kidney disease and mortality, due in part to chronic inflammation. Little is known about the effects of anti-tumor necrosis factor (TNF) therapy on kidney disease progression and mortality among patients with new-onset IBD. OBJECTIVE: To examine the association of incident use of TNF inhibitors with subsequent decline in kidney function and risk of all-cause mortality...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38625582/prevention-and-treatment-of-ischaemic-and-haemorrhagic-stroke-in-people-with-diabetes-mellitus-a-focus-on-glucose-control-and-comorbidities
#24
REVIEW
Simona Sacco, Matteo Foschi, Raffaele Ornello, Federico De Santis, Riccardo Pofi, Michele Romoli
Diabetes mellitus is a significant risk factor for both ischaemic and haemorrhagic stroke, affecting up to a third of individuals with cerebrovascular diseases. Beyond being a risk factor for stroke, diabetes and hyperglycaemia have a negative impact on outcomes after ischaemic and haemorrhagic stroke. Hyperglycaemia during the acute ischaemic stroke phase is associated with a higher risk of haemorrhagic transformation and poor functional outcome, with evidence in favour of early intervention to limit and manage severe hyperglycaemia...
April 16, 2024: Diabetologia
https://read.qxmd.com/read/38625393/correction-to-high-remnant-cholesterol-as-a-risk-factor-for-developing-chronic-kidney-disease-in-patients-with-prediabetes-and-type-2-diabetes-a-cross-sectional-study-of-a-us-population
#25
Wenting Zhu, Qiushi Liu, Fang Liu, Chenfeng Jiao, Lihua Zhang, Honglang Xie
No abstract text is available yet for this article.
April 16, 2024: Acta Diabetologica
https://read.qxmd.com/read/38623789/moringa-isothiocyanate-1-mitigates-the-damage-of-oxidative-stress-and-apoptosis-in-diabetic-nephropathy-mice
#26
JOURNAL ARTICLE
Zhou Hua, Jiuhong Deng, Guiying Wang
OBJECTIVE: Diabetic nephropathy (DN) is a prevalent cause of end-stage kidney disease worldwide. Moringa isothiocyanate-1 (MIC-1) has shown potential for DN management, however, the exact mechanisms remain unclear. This research intended to evaluate the impact and mechanism of MIC-1 on DN. METHODS: Six C57BLKS/J-db/m mice served as controls. Eighteen C57BLKS/J-db/db mice were randomly separated into three groups: db/db, db/db + irbesartan (IBS), and db/db + MIC-1...
April 16, 2024: Histology and Histopathology
https://read.qxmd.com/read/38623715/a-blood-based-multi-omic-landscape-for-the-molecular-characterization-of-kidney-stone-disease
#27
JOURNAL ARTICLE
Weibing Pan, Tianwei Yun, Xin Ouyang, Zhijun Ruan, Tuanjie Zhang, Yuhao An, Rui Wang, Peng Zhu
Kidney stone disease (KSD, also named renal calculi, nephrolithiasis, or urolithiasis) is a common urological disease entailing the formation of minerals and salts that form inside the urinary tract, frequently caused by diabetes, high blood pressure, hypertension, and monogenetic components in most patients. 10% of adults worldwide are affected by KSD, which continues to be highly prevalent and with increasing incidence. For the identification of novel therapeutic targets in KSD, we adopted high-throughput sequencing and mass spectrometry (MS) techniques in this study and carried out an integrative analysis of exosome proteomic data and DNA methylation data from blood samples of normal and KSD individuals...
April 16, 2024: Molecular Omics
https://read.qxmd.com/read/38623388/characteristics-risk-factors-and-outcomes-in-acute-kidney-injury-patients-a-retrospective-cross-sectional-study-palestine
#28
JOURNAL ARTICLE
Abdallah Damin Abukhalil, Haya Alyazouri, Reem Alsheikh, Hadeel Kahla, Minna Mousa, Hosniyeh Ladadweh, Ni'meh Al-Shami, Yousef Sahoury, Hani Naseef, Abdullah Rabba
BACKGROUND: Acute kidney injury (AKI) is a major medical problem affecting patients' quality of life and healthcare costs. OBJECTIVES: This study evaluated the severity, risk factors, and outcomes of patients diagnosed with acute kidney injury (AKI), including community-acquired AKI (CA-AKI) and hospital-acquired AKI (HA-AKI), who were admitted to tertiary institutions in Palestine. METHODS: This retrospective cross-sectional study was conducted at multiple tertiary care hospitals in Palestine by reviewing patient charts from January 2020 to March 2023...
2024: TheScientificWorldJournal
https://read.qxmd.com/read/38623264/kidney-histopathology-of-patients-with-hepatitis-c-infection-and-diabetes-mellitus-before-and-after-availability-of-direct-acting-antiviral-therapy
#29
JOURNAL ARTICLE
Vanderlene L Kung, Gabriel Giannini, Cynthia C Nast
INTRODUCTION: Type 2 diabetes mellitus (DM) and diabetic kidney disease are increasing. Hepatitis C infection (HCV) occurs in 1% of the world population and can induce several kidney diseases. DM prevalence is increased in individuals with HCV; however, kidney diseases in those with both DM and HCV have not been assessed. Direct-acting antiviral agents (DAAs) became available for HCV treatment in 2014; it is unknown if DAAs altered the spectrum of kidney disease in patients with DM and HCV...
2024: Glomerular diseases
https://read.qxmd.com/read/38623181/safety-and-efficacy-of-semaglutide-in-post-kidney-transplant-patients-with-type-2-diabetes-or-post-transplant-diabetes
#30
JOURNAL ARTICLE
Moeber Mohammed Mahzari, Omar Buraykan Alluhayyan, Mahdi Hamad Almutairi, Mohammed Abdullah Bayounis, Yazeed Hasan Alrayani, Amir A Omair, Awad Saad Alshahrani
OBJECTIVE: Type 2 diabetes mellitus (T2DM) and post-transplant diabetes mellitus (PTDM) are common in renal transplant recipients. Semaglutide has demonstrated efficacy and safety in patients with T2DM. To date, only a limited number of studies have investigated its use in renal transplant patients. This study assessed the safety and efficacy of semaglutide in post-renal transplant patients. METHODS: A retrospective study was conducted at king Abdulaziz Medical City-Riyadh, Saudi Arabia...
June 2024: Journal of Clinical & Translational Endocrinology
https://read.qxmd.com/read/38622938/antimicrobial-use-and-carbapenem-resistant-enterobacterales-in-korea-a-nationwide-case-control-study-with-propensity-score-matching
#31
JOURNAL ARTICLE
Ki Tae Kwon, Yoonjung Kim, Shin-Woo Kim, Hyun-Ha Chang, Soyoon Hwang, Sohyun Bae, Eunkyung Nam
BACKGROUND: Nationwide research on the association between carbapenem-resistant Enterobacterales (CREs) and antibiotic use is limited. METHODS: This nested case-control study analyzed Korean National Health Insurance claims data from April 2017 to April 2019. Based on the occurrence of CRE, hospitalized patients aged ≥ 18 years were classified into CRE (cases) and control groups. Propensity scores based on age, sex, modified Charlson comorbidity score, insurance type, long-term care facility, intensive care unit stay, and acquisition of vancomycin-resistant Enterococci were used to match the case and control groups (1:3)...
April 15, 2024: Journal of Korean Medical Science
https://read.qxmd.com/read/38622882/role-of-synbiotics-prebiotics-and-probiotics-as-dietary-supplements-in-type-2-diabetes-mellitus-induced-health-complications
#32
REVIEW
Kalpana Baghel, Aamir Khan, Naveen Kango
Diabetes is a metabolic disorder whose prevalence has become a worrying condition in recent decades. Chronic diabetes can result in serious health conditions such as impaired kidney function, stroke, blindness, and myocardial infarction. Despite a variety of currently available treatments, cases of diabetes and its complications are on the rise. This review article provides a comprehensive account of the ameliorative effect of prebiotics and probiotics individually or in combination i.e. synbiotics on health complications induced by Type 2 Diabetes Mellitus (T2DM)...
April 15, 2024: Journal of Dietary Supplements
https://read.qxmd.com/read/38622833/genetic-analysis-of-nephrogenic-diabetes-insipidus-patients-a-study-on-the-iranian-population
#33
JOURNAL ARTICLE
Saeed Ghasemi, Marzieh Mojbafan, Saeed Talebi, Nakysa Hooman, Rozita Hoseini
INTRODUCTION: Nephrogenic diabetes insipidus (NDI) is a rare genetic disease that causes water imbalance. The kidneys play a crucial role in regulating body fluids by controlling water balance through urine excretion. This highlights their essential function in managing the body's water levels, but individuals with NDI may have excess urine production (polyuria), that leads to excessive thirst (polydipsia). Untreated affected individuals may exhibit poor feeding and failure to thrive...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38622535/determinants-of-early-chronic-kidney-disease-in-patients-with-recently-diagnosed-type-2-diabetes-mellitus-a-retrospective-study-from-the-taiwan-diabetes-registry
#34
JOURNAL ARTICLE
Yun-Kai Yeh, Kuan-Hung Lin, Wayne Huey-Herng Sheu, Su-Huey Lo, Yen-Po Yeh, Chien-Ning Huang, Chii-Min Hwu, Chieh-Hsiang Lu
BACKGROUND: We tried to identify the risk factor associate with early chronic kidney disease (CKD) in recently diagnosed type 2 diabetes mellitus patients by utilizing real-world data from Taiwan Diabetes Registry. MATERIALS AND METHODS: Patients with type 2 diabetes mellitus recently diagnosed within 1 year. We divided the study participants into control group and early CKD group. Early CKD was defined as either CKD stage G1 with albuminuria, CKD stage G2 with albuminuria, or CKD stage G3a regardless of albuminuria (Urine-albumin to creatinine ratio (UACR) ≥ 3 mg/mmol)...
April 15, 2024: BMC Nephrology
https://read.qxmd.com/read/38621971/-evaluation-of-chemical-constituents-of-draconis-sanguis-and-its-protective-effect-on-renal-tubular-injury-in-diabetic-kidney-disease
#35
JOURNAL ARTICLE
Lu Zhou, Ya-Fei Duan, Yi-Hang Wang, Yao Ren, Xiao-Wei Zhang, Han-Wei Li, Zhen-Qiang Zhang, Jiang-Yan Xu, Pan Wang
The chemical constituents of Draconis Sanguis were preliminarily studied by macroporous resin, silica gel, dextran gel, and high-performance liquid chromatography. One retro-dihydrochalcone, four flavonoids, and one stilbene were isolated. Their chemical structures were identified as 4-hydroxy-2,6-dimethoxy-3-methyldihydrochalcone(1), 4'-hydroxy-5,7-dimethoxy-8-methylflavan(2), 7-hydroxy-4',5-dimethoxyflavan(3),(2S)-7-hydroxy-5-methoxy-6-methylflavan(4),(2S)-7-hydroxy-5-methoxyflavan(5), and pterostilbene(6) by modern spectroscopy, physicochemical properties, and literature comparison...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621963/-mechanism-of-traditional-chinese-medicine-in-regulating-nlrp3-inflammasomes-to-alleviate-renal-interstitial-fibrosis-in-diabetic-nephropathy-a-review
#36
JOURNAL ARTICLE
Lin Qiao, Yan Jin, Zhao-An Guo
Diabetic nephropathy(DN), a progressive chronic kidney disease(CKD) induced by diabetes mellitus, is the main cause of end-stage renal disease. Renal interstitial fibrosis(RIF) is an irreversible factor in the progression and deterioration of the renal function in DN. Chronic inflammation has become a key link in the pathogenesis of DN-RIF. The NOD-like receptor thermal protein domain associated protein 3(NLRP3) inflammasome is an important inflammatory regulator regulated by a variety of signals. It promotes the production of pro-inflammatory cytokines and induces renal inflammatory cell infiltration to participate in the process of renal fibrosis, demonstrating a complex mechanism of action...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621945/-mechanism-of-ultrafiltration-extract-of-angelicae-sinensis-radix-and-hedysari-radix-regulates-hif-1%C3%AE-signaling-pathway-mediated-by-renal-hypoxia-to-ameliorate-renal-fibrosis-in-dkd-rats
#37
JOURNAL ARTICLE
Xiao-Lin Zhang, Rong-Ke Li, Ting Gao, Qing-Quan Xu, Sheng-Fang Wan, Lei Zhang, Tian-Yi Lu
This study explored the mechanism of the ultrafiltration extract of Angelicae Sinensis Radix and Hedysari Radix in ameliorating renal fibrosis in the rat model of diabetic kidney disease(DKD) based on the expression of hypoxia-inducible factor-1α(HIF-1α)/vascular endothelial growth factor(VEGF) and HIF-1α/platelet-derived growth factor(PDGF)/platelet-derived growth factor receptor(PDGFR) signaling pathways in the DKD rats. After 1 week of adaptive feeding, 50 male SPF-grade Wistar rats were randomized into a blank group(n=7) and a modeling group...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621801/predicting-the-risks-of-kidney-failure-and-death-in-adults-with-moderate-to-severe-chronic-kidney-disease-multinational-longitudinal-population-based-cohort-study
#38
JOURNAL ARTICLE
Ping Liu, Simon Sawhney, Uffe Heide-Jørgensen, Robert Ross Quinn, Simon Kok Jensen, Andrew Mclean, Christian Fynbo Christiansen, Thomas Alexander Gerds, Pietro Ravani
OBJECTIVE: To train and test a super learner strategy for risk prediction of kidney failure and mortality in people with incident moderate to severe chronic kidney disease (stage G3b to G4). DESIGN: Multinational, longitudinal, population based, cohort study. SETTINGS: Linked population health data from Canada (training and temporal testing), and Denmark and Scotland (geographical testing). PARTICIPANTS: People with newly recorded chronic kidney disease at stage G3b-G4, estimated glomerular filtration rate (eGFR) 15-44 mL/min/1...
April 15, 2024: BMJ: British Medical Journal
https://read.qxmd.com/read/38620082/accelerated-risk-based-implementation-of-guideline-directed-medical-therapy-for-type-2-diabetes-and-chronic-kidney-disease
#39
JOURNAL ARTICLE
Brendon L Neuen, Katherine R Tuttle, Muthiah Vaduganathan
No abstract text is available yet for this article.
April 16, 2024: Circulation
https://read.qxmd.com/read/38619822/sodium-glucose-cotransporter-2-inhibitors-vs-sulfonylureas-for-gout-prevention-among-patients-with-type-2-diabetes-receiving-metformin
#40
JOURNAL ARTICLE
Natalie McCormick, Chio Yokose, Na Lu, Deborah J Wexler, J Antonio Aviña-Zubieta, Mary A De Vera, Rozalina G McCoy, Hyon K Choi
IMPORTANCE: Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) are a revolutionary treatment for type 2 diabetes (T2D) with cardiovascular, kidney, and serum urate-lowering benefits. OBJECTIVE: To compare risk of incident gout and rate of recurrent flares between patients with T2D initiating SGLT2i vs sulfonylurea, most common second-line glucose-lowering therapy, when added to metformin monotherapy. DESIGN, SETTING, AND PARTICIPANTS: This sequential, propensity score-matched, new-user comparative effectiveness study using target trial emulation framework included adults with T2D receiving metformin monotherapy in a Canadian general population database from January 1, 2014, to June 30, 2022...
April 15, 2024: JAMA Internal Medicine
keyword
keyword
76369
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.